Similar articles for PMID: 18941743

Year	Number of Results
1999	5
2000	1
2001	9
2002	1
2003	3
2004	2
2005	6
2006	5
2007	6
2008	4
2009	9
2010	6
2011	13
2012	6
2013	3
2014	4
2015	2
2016	5
2017	5
2018	5
2019	1
2020	4
2021	4
2022	1
2023	1
2024	0

1

Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.

Karagiannis P, Singer J, Hunt J, Gan SK, Rudman SM, Mechtcheriakova D, Knittelfelder R, Daniels TR, Hobson PS, Beavil AJ, Spicer J, Nestle FO, Penichet ML, Gould HJ, Jensen-Jarolim E, Karagiannis SN. Karagiannis P, et al. Cancer Immunol Immunother. 2009 Jun;58(6):915-30. doi: 10.1007/s00262-008-0607-1. Epub 2008 Oct 22. Cancer Immunol Immunother. 2009. PMID: 18941743 Free PMC article.

2

Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients.

Petricevic B, Laengle J, Singer J, Sachet M, Fazekas J, Steger G, Bartsch R, Jensen-Jarolim E, Bergmann M. Petricevic B, et al. J Transl Med. 2013 Dec 12;11:307. doi: 10.1186/1479-5876-11-307. J Transl Med. 2013. PMID: 24330813 Free PMC article.

3

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

Cooley S, Burns LJ, Repka T, Miller JS. Cooley S, et al. Exp Hematol. 1999 Oct;27(10):1533-41. doi: 10.1016/s0301-472x(99)00089-2. Exp Hematol. 1999. PMID: 10517495 Free article.

4

Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.

Watanabe M, Wallace PK, Keler T, Deo YM, Akewanlop C, Hayes DF. Watanabe M, et al. Breast Cancer Res Treat. 1999 Feb;53(3):199-207. doi: 10.1023/a:1006145507567. Breast Cancer Res Treat. 1999. PMID: 10369066

5

Differential regulation of human monocytes and NK cells by antibody-opsonized tumors.

Yin J, Albers AJ, Smith TS, Riddell GT, Richards JO. Yin J, et al. Cancer Immunol Immunother. 2018 Aug;67(8):1239-1250. doi: 10.1007/s00262-018-2179-z. Epub 2018 May 31. Cancer Immunol Immunother. 2018. PMID: 29855696

6

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM, Fox JA. Sliwkowski MX, et al. Semin Oncol. 1999 Aug;26(4 Suppl 12):60-70. Semin Oncol. 1999. PMID: 10482195 Review.

7

Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance.

Upton R, Banuelos A, Feng D, Biswas T, Kao K, McKenna K, Willingham S, Ho PY, Rosental B, Tal MC, Raveh T, Volkmer JP, Pegram MD, Weissman IL. Upton R, et al. Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2026849118. doi: 10.1073/pnas.2026849118. Proc Natl Acad Sci U S A. 2021. PMID: 34257155 Free PMC article.

8

Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

Reim F, Dombrowski Y, Ritter C, Buttmann M, Häusler S, Ossadnik M, Krockenberger M, Beier D, Beier CP, Dietl J, Becker JC, Hönig A, Wischhusen J. Reim F, et al. Cancer Res. 2009 Oct 15;69(20):8058-66. doi: 10.1158/0008-5472.CAN-09-0834. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826050

9

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.

El-Sahwi K, Bellone S, Cocco E, Cargnelutti M, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. El-Sahwi K, et al. Br J Cancer. 2010 Jan 5;102(1):134-43. doi: 10.1038/sj.bjc.6605448. Epub 2009 Nov 17. Br J Cancer. 2010. PMID: 19920829 Free PMC article.

10

Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.

Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P. Borrok MJ, et al. MAbs. 2015;7(4):743-51. doi: 10.1080/19420862.2015.1047570. MAbs. 2015. PMID: 25970007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year